H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal
2025 · 3rd Quarter (July 1 - Sep 30)
VERTEX PHARMACEUTICALS INCORPORATED
Filed by AVENUE SOLUTIONS.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- AVENUE SOLUTIONS
- Filing UUID
- aa52273b-de1b-4ac1-b56d-7a78546d6e8d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Monitor issues related to 340b; Expiring healthcare extenders
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.